Difference between revisions of "DZI20-203-Case-5"
From MGH Learn Pathology
(Automatic edit to upgrade to new templates) |
(Added status template) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 12: | Line 12: | ||
Final: adenocarcinoma (50% lepidic, 40% acinar, 10% papillary). Lymph node: granulomatous inflammation | Final: adenocarcinoma (50% lepidic, 40% acinar, 10% papillary). Lymph node: granulomatous inflammation | ||
|reasonCode=74 yo F with RLL mass | |reasonCode=74 yo F with RLL mass | ||
| − | |subject= | + | |subject=MGH |
| − | |performer= | + | |performer=YPH1 |
|authoredOn=October 22, 2020 12:52:14 PM | |authoredOn=October 22, 2020 12:52:14 PM | ||
|requester=Mjf79 | |requester=Mjf79 | ||
|sequence=5 | |sequence=5 | ||
| + | |access=public | ||
}} | }} | ||
{{Media | {{Media | ||
| Line 43: | Line 44: | ||
|subject=Z0FBQUFBQmZrWUNnZU9XcDdFUHM0QVpqdU9zdVNKMmIzVm95Z3VoX0tuaHo2UjAtT2lNZ2J4UzFkVS1Kbk5CR0pRSnZUTE5paFM3SWp5S3hsOFZFV2ZINk16Z2VWSDVzVUE9PQ | |subject=Z0FBQUFBQmZrWUNnZU9XcDdFUHM0QVpqdU9zdVNKMmIzVm95Z3VoX0tuaHo2UjAtT2lNZ2J4UzFkVS1Kbk5CR0pRSnZUTE5paFM3SWp5S3hsOFZFV2ZINk16Z2VWSDVzVUE9PQ | ||
|modality=mrxs | |modality=mrxs | ||
| + | }} | ||
| + | {{status | ||
| + | |status=active | ||
| + | |requester=Mjf79 | ||
| + | |authoredOn=October 22, 2020 12:52:14 PM | ||
}} | }} | ||
Latest revision as of 14:00, December 9, 2024
